Clinical Trials Directory

Trials / Completed

CompletedNCT00484107

Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women

A Postmarketing Surveillance Study Evaluating the Tolerability and Safety of PREMARIN VAGINAL CREAM in Indian Postmenopausal Women

Status
Completed
Phase
—
Study type
Observational
Enrollment
200 (planned)
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer · Industry
Sex
Female
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This post-marketing study will provide local safety and tolerance data on the use of Premarin® vaginal cream.

Conditions

Interventions

TypeNameDescription
DRUGConjugated Estrogen Cream (Premarin®)

Timeline

Start date
2005-09-01
Completion
2006-10-01
First posted
2007-06-08
Last updated
2007-12-28

Source: ClinicalTrials.gov record NCT00484107. Inclusion in this directory is not an endorsement.

Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women (NCT00484107) · Clinical Trials Directory